RecruitingNCT06413433
About this title
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Read the official source — NCT06413433Official study titleA Phase 3, Randomized, Double-blind, Placebo-Controlled Trial of Solriamfetol in Adults With Binge Eating Disorder (BED)
Multiple locations, including EncinoEating disordersMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Axsome Therapeutics, Inc.
RecruitingNCT07490353
About this title
Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Read the official source — NCT07490353Official study titleElucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects: A Randomized, Open-Label, Cross-Over Functional Magnetic Resonance Imaging Trial
In ViennaDepressionMedication studyAges 18–55
- Countries
- Austria
- Sponsor
- Medical University of Vienna
RecruitingNCT06777563
About this title
EMA and mHealth in Preventing Postpartum Depression
Read the official source — NCT06777563Official study titleEcological Momentary Assessment Combined mHealth-based Psychosocial Intervention to Prevent Postpartum Depression in Pregnant Women: a Pilot Randomized Controlled Trial
In Hong KongDepressionBehavioural studyAges 18+
- Countries
- China
- Sponsor
- The University of Hong Kong